179 Promenade du Portage
3rd Floor Suite 300
Gatineau, QC J8X 2K5
Canada
819-718-2042
https://www.eureka93.com
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Seann Poli | Co-CEO & Director | 181.74k | N/A | 1968 |
Mr. Peter Ostapchuk | Chief Financial Officer | 3.68k | N/A | N/A |
Owen Kenney | Co-CEO & Director | N/A | N/A | N/A |
Eureka 93 Inc., a cannabidiol (CBD) life sciences company, engages in the research, development, extraction, production, processing, and distribution of CBD and other cannabinoids in the United States and Canada. The company offers hemp-derived CBD products, full plant extracts, and isolate powder. It is also involved in the development and manufacture of natural health products, as well as nutraceutical contract manufacturing business. The company is headquartered in Gatineau, Canada.
Eureka 93 Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.